Skip to main content
. Author manuscript; available in PMC: 2014 Sep 13.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008041. doi: 10.1002/14651858.CD008041.pub2
Associated symptoms: symptom present 2 hours after taking study medication
Intervention Studies Attacks treated Treatment (%) Placebo (%) Relative risk (95% CI) NNTp (95% CI)
Nausea
Aspirin 1000 mg versus placebo 4 1446 26 33 0.79 (0.68 to 0.93) 14 (8.6 to 45)
Aspirin 900 mg plus metoclopramide 10 mg versus placebo 2 735 34 49 0.69 (0.58 to 0.82) 6.7 (4.6 to 13)
Aspirin 900 mg plus metoclopramide 10 mg versus sumatriptan 100 mg 2 612 45 45 0.99 (0.83 to 1.2) Not calculated
Vomiting
Aspirin 1000 mg versus placebo 3 1182 3 4 0.77 (0.43 to 1.4) Not calculated
Aspirin 900 mg plus metoclopramide 10 mg versus placebo 2 728 4 11 0.33 (0.18 to 0.59) 13 (8.8 to 26)
Aspirin 900 mg plus metoclopramide 10 mg versus sumatriptan 100 mg 2 608 8 13 0.63 (0.39 to 1.02) Not calculated
Photophobia
Aspirin 1000 mg versus placebo 5 1639 42 52 0.79 (0.72 to 0.87) 9.2 (6.4 to 17)
Aspirin 1000 mg versus sumatriptan 50 mg 2 726 32 27 1.2 (0.94 to 1.5) Not calculated
Phonophobia
Aspirin 1000 mg versus placebo 5 1639 37 49 0.75 (0.68 to 0.84) 8.3 (6.0 to 14)
Aspirin 1000 mg versus sumatriptan 50 mg 2 726 28 26 1.05 (0.83 to 1.3) Not calculated